205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.69%
Net income growth under 50% of MCHP's 14.89%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.05%
Lower 'other non-cash' growth vs. MCHP's 575.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
4.31%
Some CFO growth while MCHP is negative at -10.34%. John Neff would note a short-term liquidity lead over the competitor.
-33.93%
Negative yoy CapEx while MCHP is 28.13%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
38.35%
Purchases growth of 38.35% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-22.75%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-55.79%
We reduce yoy invests while MCHP stands at 59.31%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-64.71%
Both yoy lines negative, with MCHP at -88.97%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.